Skip to content
OpenCapital
Get started

Opko Health OPK Changes In Fair Value Gain Loss In Equity Securities Fvni And Derivative Instruments

Changes In Fair Value Gain Loss In Equity Securities Fvni And Derivative Instruments at other companies

TFI
Triumph FinancialTFIN
-$245K-300%
Block logo
BlockXYZ
-$5.67M-4,396%
Simon Property Group logo
Simon Property GroupSPG
$25.39M+169%
City Holding Company logo
City Holding CompanyCHCO
-$100.25K+84.9%
Phillips 66 logo
Phillips 66PSX
-$9M+10.0%
Safety Insurance Group logo
Safety Insurance GroupSAFT
-$200.5K—

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%
EPS (diluted)-$0.07+30.0%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.14B+11.5%
P/S2×+0.5×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0×0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept opk:ChangesInFairValueGainLossInEquitySecuritiesFvniAndDerivativeInstruments.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's changes in fair value gain loss in equity securities fvni and derivative instruments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's changes in fair value gain loss in equity securities fvni and derivative instruments?
Opko Health (OPK) reported changes in fair value gain loss in equity securities fvni and derivative instruments of -$3.93M in Q1 2026.
How has Opko Health's changes in fair value gain loss in equity securities fvni and derivative instruments changed year-over-year?
Opko Health's changes in fair value gain loss in equity securities fvni and derivative instruments decreased by 65.3% year-over-year, from -$2.38M to -$3.93M.
What is the long-term trend for Opko Health's changes in fair value gain loss in equity securities fvni and derivative instruments?
Over 2 years (2021 to 2024), Opko Health's changes in fair value gain loss in equity securities fvni and derivative instruments has grown at a 437.1% compound annual growth rate (CAGR), from -$3.97M to $114.43M.
What does changes in fair value gain loss in equity securities fvni and derivative instruments mean?
Reflects the unrealized gains or losses resulting from fluctuations in the market value of equity securities and derivative instruments held by the company. This metric captures the impact of market volatility on the company's investment portfolio or hedging activities. It helps investors understand the non-operating earnings volatility driven by financial market movements.